Skip to main content
. 2020 Sep 10;2020:4251682. doi: 10.1155/2020/4251682

Table 2.

Effects of LPS treatment or CLP on hepatic injury and renal function in 5/6 nephrectomized mice.

Parameter 5/6 nephrectomized mice (sham) 5/6 nephrectomized mice
PBS treated (n = 6) LPS (2 mg/kg) treated (n = 6) PBS treated (n = 6) LPS (2 mg/kg) treated (n = 6)
Urea (mM/L) 8.10 ± 0.32 15.92 ± 2.11 16.98 ± 1.02a 37.65 ± 1.85a,b
Creatinine (μM/L) 29.86 ± 0.78 30.17 ± 2.57 44.94 ± 2.55a 58.12 ± 2.44a,b
ALT (U/L) 26.75 ± 2.74 51.55 ± 1.88 31.88 ± 2.88 82.54 ± 9.44a,b

Sham operated (n = 6) CLP (n = 6) Sham operated (n = 6) CLP (n = 6)
Urea (mM/L) 8.12 ± 0.55 12.95 ± 1.02 17.23 ± 0.55 36.87 ± 5.88a,b
Creatinine (μM/L) 28.65 ± 2.54 26.80 ± 1.44 45.22 ± 2.22 66.85 ± 11.22a
ALT (U/L) 22.87 ± 2.11 98.88 ± 13.11 41.65 ± 7.56 257.22 ± 41.98a,b

The blood creatinine, urea, and ALT levels were analyzed at 18 hrs in mice treated with LPS (2 mg/kg) and at 24 hrs in mice subjected to CLP. The results are presented as mean ± SEM. One-way ANOVA was done followed by Bonferroni post hoc test. aP < 0.05 against the 5/6 nephrectomy group with mentioned treatment. bP < 0.05 against the respective PBS or sham group.